King, A. C., & Orozco, J. S. (2019). Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma. J Adv Pract Oncol.
استشهاد بنمط شيكاغوKing, Amber C., و Jennifer S. Orozco. "Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma." J Adv Pract Oncol 2019.
MLA استشهادKing, Amber C., و Jennifer S. Orozco. "Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma." J Adv Pract Oncol 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.